Medical Device Regulatory Framework in France

Emi Lecret • September 16, 2026

Medical devices placed on the French market are primarily regulated under the EU medical device framework, supplemented by national French legislation and requirements.

Regulation (EU) 2017/745 (MDR)

The main European regulatory framework for medical devices, covering market access, conformity assessment, safety and performance, post-market surveillance and vigilance.

Regulation (EU) 2017/746 (IVDR)

The European regulatory framework applicable specifically to in vitro diagnostic medical devices.

French Public Health Code (Code de la santé publique)

Supplements EU legislation with national provisions governing medical devices in France.

French National Agency for the Safety of Medicines and Health Products (Agence nationale de sécurité du médicament et des produits de santé, ANSM)

The French competent authority responsible for market surveillance, vigilance, clinical investigations and regulatory oversight of medical devices.

CE Marking

CE marking (European Conformity) is required before a medical device can be placed on the market, subject to the applicable conformity assessment procedure and device classification. It indicates that the manufacturer declares that the device complies with the applicable EU regulatory requirements and can be placed on the market in the European Economic Area.

Harmonised and technical standards

It includes ISO 13485 for quality management systems, ISO 14971 for risk management, IEC 62366-1 for usability engineering and, where applicable, IEC 62304 for medical device software.

French language requirements

Information supplied with devices intended for users or patients in France must comply with applicable EU and national language requirements.

General Data Protection Regulation (GDPR)

The GRPR applies where medical devices involve the processing of personal data, including health data.

Clinical investigation requirements

Governed primarily by the MDR and supplemented in France by the Public Health Code and ANSM/ethics committee procedures.

Post-market surveillance and materiovigilance

EU PMS and vigilance requirements are supplemented by the French materiovigilance system overseen by ANSM.

emi lecret

Emi Lecret – Medical writer | Translator | Localization specialist | Communication strategist for MedTech companies


Share

clinician using a medical device user interface
By Emi Lecret September 7, 2026
How inconsistent terminology between medical device IFUs and UIs can affect usability, patient safety, regulatory approval, and French localisation quality.
By Emi Lecret August 25, 2026
Healthcare trade shows create a concentrated environment in which MedTech, HealthTech and digital health companies can demonstrate products, meet healthcare professionals, speak with hospital buyers, identify distributors, develop partnerships and generate new business opportunities. For international companies exhibiting in France or another French-speaking market, MedTech marketing content plays an important role throughout that journey. Visitors may encounter a company before the event through a campaign or exhibitor profile, discover its technology on the stand, scan a QR code during a demonstration and return to a landing page afterwards.  Effective MedTech trade show marketing therefore depends on creating a coherent sequence of interactions rather than a collection of isolated materials. The language, terminology, product story and calls to action should help the right visitors understand what the technology does, why it may be relevant to them and what they should do next.
surgical robot
By Emi Lecret August 17, 2026
Learn how to write a credible medical device white paper with strong evidence, a clear structure, compliant claims, and content tailored to your target audience.